ProCA1.GRPR: a new imaging agent in cancer detection.
作者信息
Pu Fan, Xue Shenghui, Yang Jenny J
机构信息
Department of Chemistry, Georgia State University, Atlanta, GA 30303, USA.
Inlighta Biosciences LLC, Marietta, GA 30068, USA.
出版信息
Biomark Med. 2016 May;10(5):449-52. doi: 10.2217/bmm-2016-0040. Epub 2016 Apr 13.
Abstract
摘要
相似文献
1
ProCA1.GRPR: a new imaging agent in cancer detection.前列腺特异性抗原1.胃泌素释放肽受体：一种用于癌症检测的新型成像剂。
Biomark Med. 2016 May;10(5):449-52. doi: 10.2217/bmm-2016-0040. Epub 2016 Apr 13.
2
GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.用于通过磁共振成像对癌症中受体表达进行分子成像的靶向胃泌素释放肽受体的蛋白质造影剂。
Sci Rep. 2015 Nov 18;5:16214. doi: 10.1038/srep16214.
3
Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.使用荧光和放射性镓标记的胃泌素释放肽受体拮抗剂对前列腺癌进行双模态成像
J Nucl Med. 2017 Jan;58(1):29-35. doi: 10.2967/jnumed.116.176099. Epub 2016 Aug 11.
4
5
Bombesin-Targeted PET of Prostate Cancer.前列腺癌的蛙皮素靶向正电子发射断层显像
J Nucl Med. 2016 Oct;57(Suppl 3):67S-72S. doi: 10.2967/jnumed.115.170977.
6
18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.用于靶向表达胃泌素释放肽受体的前列腺癌的18F标记的蛙皮素类似物。
J Nucl Med. 2006 Mar;47(3):492-501.
7
18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors.18F 标记的蛙皮素类似物，用于特异性和有效地靶向表达胃泌素释放肽受体的前列腺肿瘤。
J Nucl Med. 2011 Feb;52(2):270-8. doi: 10.2967/jnumed.110.081620. Epub 2011 Jan 13.
8
Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.（177）Lu标记的糖化蛙皮素类似物用于胃泌素释放肽受体阳性前列腺肿瘤靶向的临床前药代动力学、生物分布、成像及治疗效果
Nucl Med Biol. 2015 Mar;42(3):234-41. doi: 10.1016/j.nucmedbio.2014.10.008. Epub 2014 Oct 22.
9
Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.新型 ¹¹¹In 标记的铃蟾素同二聚体用于 GRPR 阳性前列腺癌成像的临床前评估。
Mol Pharm. 2013 May 6;10(5):1716-24. doi: 10.1021/mp3005462. Epub 2013 Apr 16.
10
Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.用（64）铜标记的RGD-蛙皮素异二聚体对肿瘤进行小动物正电子发射断层扫描。
J Nucl Med. 2009 Jul;50(7):1168-77. doi: 10.2967/jnumed.108.061739. Epub 2009 Jun 12.
引用本文的文献
1
[In]In-AMBA: A Novel Diagnostic Agent for SPECT Imaging of GRPR-Expressing Tumors.铟 - 标记的促胃液素释放肽受体拮抗剂（In-AMBA）：一种用于促胃液素释放肽受体（GRPR）表达肿瘤单光子发射计算机断层扫描（SPECT）成像的新型诊断剂。
Nucl Med Mol Imaging. 2025 Apr;59(2):125-134. doi: 10.1007/s13139-025-00906-4. Epub 2025 Feb 3.
2
Synthesis, preclinical, and initial clinical evaluation of integrin αβ and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [Ga]Ga-RGD-RM26-03.整合素αβ与胃泌素释放肽受体（GRPR）双靶点放射性示踪剂[Ga]Ga-RGD-RM26-03的合成、临床前及初步临床评估
Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):2023-2035. doi: 10.1007/s00259-024-06634-9. Epub 2024 Feb 20.
3
In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor.靶向胃泌素释放肽受体（GRPR）的放射性示踪剂NeoB在携带胃肠道间质瘤小鼠体内的生物分布及疗效评估
Cancers (Basel). 2021 Mar 2;13(5):1051. doi: 10.3390/cancers13051051.
4
Insulin Hexamer-Caged Gadolinium Ion as MRI Contrast-o-phore.胰岛素六聚体笼状钆离子作为 MRI 对比剂。
Chemistry. 2018 Jul 25;24(42):10646-10652. doi: 10.1002/chem.201801388. Epub 2018 Jul 4.
本文引用的文献
1
Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents.利用基于蛋白质的MRI造影剂实现前列腺癌生物标志物的分子成像
Curr Protein Pept Sci. 2016;17(6):519-33. doi: 10.2174/1389203717666160101123725.
2
GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.用于通过磁共振成像对癌症中受体表达进行分子成像的靶向胃泌素释放肽受体的蛋白质造影剂。
Sci Rep. 2015 Nov 18;5:16214. doi: 10.1038/srep16214.
3
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy.靶向胃泌素释放肽受体、生长抑素受体2或趋化因子C-X-C基序受体4在乳腺癌成像和治疗中的临床相关性
J Nucl Med. 2015 Oct;56(10):1487-93. doi: 10.2967/jnumed.115.160739. Epub 2015 Aug 6.
4
Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging.具有前所未有的金属选择性和肝癌成像敏感性的蛋白质磁共振成像造影剂。
Proc Natl Acad Sci U S A. 2015 May 26;112(21):6607-12. doi: 10.1073/pnas.1423021112. Epub 2015 May 13.
5
Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers.高剂量效率和用于癌症生物标志物分子成像的 ProCAs（基于蛋白质的 Gd(3+) MRI 对比剂）的设计。
Med Res Rev. 2014 Sep;34(5):1070-99. doi: 10.1002/med.21313. Epub 2014 Mar 11.
6
Gastrin-releasing peptide receptor expression in lung cancer.肺癌中胃泌素释放肽受体的表达。
Arch Pathol Lab Med. 2014 Jan;138(1):98-104. doi: 10.5858/arpa.2012-0679-OA.
7
Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents.蛋白质 MRI 对比剂对 EGFR/HER2 癌症生物标志物的分子成像。
J Biol Inorg Chem. 2014 Feb;19(2):259-70. doi: 10.1007/s00775-013-1076-3. Epub 2013 Dec 24.
8
Cancer genome landscapes.肿瘤基因组图谱。
Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
9
Targeting GRPR in urological cancers--from basic research to clinical application.靶向 GRPR 在泌尿系统癌症中的应用——从基础研究到临床应用。
Nat Rev Urol. 2013 Apr;10(4):235-44. doi: 10.1038/nrurol.2013.42. Epub 2013 Mar 19.
10
Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers.设计一类新型基于蛋白质的磁共振成像对比剂用于癌症生物标志物的分子成像。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Mar-Apr;5(2):163-79. doi: 10.1002/wnan.1205. Epub 2013 Jan 17.
Zotero 插件